| 1 |
Abdelmaksoud NM, El-Mahdy HA, Ismail A, Elsakka EGE, El-Husseiny AA, Khidr EG, Ali EM, Rashed MH, El-Demerdash FE, Doghish AS. The role of miRNAs in the pathogenesis and therapeutic resistance of endometrial cancer: a spotlight on the convergence of signaling pathways. Pathol Res Pract 2023;244:154411. [PMID: 36921547 DOI: 10.1016/j.prp.2023.154411] [Reference Citation Analysis]
|
| 2 |
Doghish AS, Abulsoud AI, Elshaer SS, Abdelmaksoud NM, Zaki MB, El-Mahdy HA, Ismail A, Fathi D, Elsakka EGE. miRNAs as cornerstones in chronic lymphocytic leukemia pathogenesis and therapeutic resistance- An emphasis on the interaction of signaling pathways. Pathol Res Pract 2023;243:154363. [PMID: 36764011 DOI: 10.1016/j.prp.2023.154363] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 3 |
Doghish AS, Elballal MS, Elazazy O, Elesawy AE, Elrebehy MA, Shahin RK, Midan HM, Sallam AM. The role of miRNAs in liver diseases: Potential therapeutic and clinical applications. Pathol Res Pract 2023;243:154375. [PMID: 36801506 DOI: 10.1016/j.prp.2023.154375] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 4 |
Doghish AS, El-Mahdy HA, Ismail A, Hegazy M, Mokhtar MM, Elkhawaga SY, Elkady MA, Yehia AM, Elsakka EGE. Significance of miRNAs on the thyroid cancer progression and resistance to treatment with special attention to the role of cross-talk between signaling pathways. Pathol Res Pract 2023;243:154371. [PMID: 36791561 DOI: 10.1016/j.prp.2023.154371] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 5 |
Abdel Mageed SS, Doghish AS, Ismail A, El-Husseiny AA, Fawzi SF, Mahmoud AMA, El-Mahdy HA. The role of miRNAs in insulin resistance and diabetic macrovascular complications - A review. Int J Biol Macromol 2023;230:123189. [PMID: 36623613 DOI: 10.1016/j.ijbiomac.2023.123189] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 6 |
Doghish AS, Ali MA, Elyan SS, Elrebehy MA, Mohamed HH, Mansour RM, Elgohary A, Ghanem A, Faraag AHI, Abdelmaksoud NM, Moustafa HAM. miRNAs role in cervical cancer pathogenesis and targeted therapy: Signaling pathways interplay. Pathol Res Pract 2023;244:154386. [PMID: 36868096 DOI: 10.1016/j.prp.2023.154386] [Reference Citation Analysis]
|
| 7 |
Abdallah AE, Eissa IH, Mehany AB, Sakr H, Atwa A, El-adl K, El-zahabi MA. Immunomodulatory quinazoline-based thalidomide analogs: Design, synthesis, apoptosis and anticancer evaluations. Journal of Molecular Structure 2023. [DOI: 10.1016/j.molstruc.2023.135164] [Reference Citation Analysis]
|
| 8 |
El-Mahdy HA, Elsakka EGE, El-Husseiny AA, Ismail A, Yehia AM, Abdelmaksoud NM, Elshimy RAA, Noshy M, Doghish AS. miRNAs role in bladder cancer pathogenesis and targeted therapy: Signaling pathways interplay - A review. Pathol Res Pract 2023;242:154316. [PMID: 36682282 DOI: 10.1016/j.prp.2023.154316] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 9 |
Ismail A, El-Mahdy HA, Eldeib MG, Doghish AS. miRNAs as cornerstones in diabetic microvascular complications. Mol Genet Metab 2023;138:106978. [PMID: 36565688 DOI: 10.1016/j.ymgme.2022.106978] [Reference Citation Analysis]
|
| 10 |
Taghour MS, Elkady H, Eldehna WM, El-Deeb NM, Kenawy AM, Elkaeed EB, Alsfouk AA, Alesawy MS, Metwaly AM, Eissa IH. Design and synthesis of thiazolidine-2,4-diones hybrids with 1,2-dihydroquinolones and 2-oxindoles as potential VEGFR-2 inhibitors: in-vitro anticancer evaluation and in-silico studies. J Enzyme Inhib Med Chem 2022;37:1903-17. [PMID: 35801403 DOI: 10.1080/14756366.2022.2085693] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 11 |
Nossier ES, Alasfoury RA, Hagras M, El-manawaty M, Sayed SM, Ibrahim IM, Elkady H, Eissa IH, Elzahabi HS. Modified pyrido[2,3-d]pyrimidin-4(3H)-one derivatives as EGFRWT and EGFRT790M inhibitors: Design, synthesis, and anti-cancer evaluation. Journal of Molecular Structure 2022;1270:133971. [DOI: 10.1016/j.molstruc.2022.133971] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Taghour MS, Mahdy HA, Gomaa MH, Aglan A, Eldeib MG, Elwan A, Dahab MA, Elkaeed EB, Alsfouk AA, Khalifa MM, Eissa IH, Elkady H. Benzoxazole derivatives as new VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, in silico studies, and antiproliferative evaluation. J Enzyme Inhib Med Chem 2022;37:2063-77. [PMID: 35875937 DOI: 10.1080/14756366.2022.2103552] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 13 |
Kotb AR, Bakhotmah DA, Abdallah AE, Elkady H, Taghour MS, Eissa IH, El-Zahabi MA. Design, synthesis, and biological evaluation of novel bioactive thalidomide analogs as anticancer immunomodulatory agents. RSC Adv 2022;12:33525-39. [PMID: 36505721 DOI: 10.1039/d2ra06188k] [Reference Citation Analysis]
|
| 14 |
Yousef RG, Elkady H, Elkaeed EB, Gobaara IMM, Al-Ghulikah HA, Husein DZ, Ibrahim IM, Metwaly AM, Eissa IH. (E)-N-(3-(1-(2-(4-(2,2,2-Trifluoroacetamido)benzoyl)hydrazono)ethyl)phenyl)nicotinamide: A Novel Pyridine Derivative for Inhibiting Vascular Endothelial Growth Factor Receptor-2: Synthesis, Computational, and Anticancer Studies. Molecules 2022;27. [PMID: 36431818 DOI: 10.3390/molecules27227719] [Reference Citation Analysis]
|
| 15 |
Ismail A, Abulsoud AI, Fathi D, Elshafei A, El-mahdy HA, Elsakka EG, Aglan A, Elkhawaga SY, Doghish AS. The role of miRNAs in Ovarian Cancer Pathogenesis and Therapeutic Resistance - A Focus on Signaling Pathways Interplay. Pathology - Research and Practice 2022. [DOI: 10.1016/j.prp.2022.154222] [Reference Citation Analysis]
|
| 16 |
Ismail A, El-mahdy HA, Abulsoud AI, Sallam AM, Eldeib MG, Elsakka EG, Zaki MB, Doghish AS. Beneficial and detrimental aspects of miRNAs as chief players in breast cancer: A comprehensive review. International Journal of Biological Macromolecules 2022. [DOI: 10.1016/j.ijbiomac.2022.10.241] [Reference Citation Analysis]
|
| 17 |
Elkaeed EB, Yousef RG, Elkady H, Mehany ABM, Alsfouk BA, Husein DZ, Ibrahim IM, Metwaly AM, Eissa IH. In silico, in vitro VEGFR-2 inhibition, and anticancer activity of a 3-(hydrazonomethyl)naphthalene-2-ol derivative. J Biomol Struct Dyn 2022;:1-16. [PMID: 36184591 DOI: 10.1080/07391102.2022.2127907] [Reference Citation Analysis]
|
| 18 |
Elkaeed EB, Yousef RG, Khalifa MM, Ibrahim A, Mehany ABM, Gobaara IMM, Alsfouk BA, Eldehna WM, Metwaly AM, Eissa IH, El-zahabi MA. Discovery of New VEGFR-2 Inhibitors: Design, Synthesis, Anti-Proliferative Evaluation, Docking, and MD Simulation Studies. Molecules 2022;27:6203. [DOI: 10.3390/molecules27196203] [Reference Citation Analysis]
|
| 19 |
Elkaeed EB, Yousef RG, Elkady H, Alsfouk AA, Husein DZ, Ibrahim IM, Metwaly AM, Eissa IH. New Anticancer Theobromine Derivative Targeting EGFRWT and EGFRT790M: Design, Semi-Synthesis, In Silico, and In Vitro Anticancer Studies. Molecules 2022;27:5859. [PMID: 36144596 DOI: 10.3390/molecules27185859] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 20 |
Korkmaz A, Kurtay G, Kaya E, Bursal E. Design, synthesis, spectroscopic characterizations, in vitro pancreatic lipase as well as tyrosinase inhibition evaluations and in silico analysis of novel aryl sulfonate-naphthalene hybrids. J Biomol Struct Dyn 2022;:1-16. [PMID: 36069113 DOI: 10.1080/07391102.2022.2116600] [Reference Citation Analysis]
|
| 21 |
Doghish AS, Ismail A, Elrebehy MA, Elbadry AM, Mahmoud HH, Farouk SM, Serea GAA, Elghany RAA, El-halwany KK, Alsawah AO, Dewidar HI, El-mahdy HA. A study of miRNAs as cornerstone in lung cancer pathogenesis and therapeutic resistance: A focus on signaling pathways interplay. Pathology - Research and Practice 2022;237:154053. [DOI: 10.1016/j.prp.2022.154053] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 22 |
Salem SS, Hashem AH, Sallam AM, Doghish AS, Al-askar AA, Arishi AA, Shehabeldine AM. Synthesis of Silver Nanocomposite Based on Carboxymethyl Cellulose: Antibacterial, Antifungal and Anticancer Activities. Polymers 2022;14:3352. [DOI: 10.3390/polym14163352] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 23 |
Elwan A, Abdallah AE, Mahdy HA, Dahab MA, Taghour MS, Elkaeed EB, Mehany ABM, Nabeeh A, Adel M, Alsfouk AA, Elkady H, Eissa IH. Modified Benzoxazole-Based VEGFR-2 Inhibitors and Apoptosis Inducers: Design, Synthesis, and Anti-Proliferative Evaluation. Molecules 2022;27:5047. [PMID: 35956997 DOI: 10.3390/molecules27155047] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 24 |
Elkaeed EB, Yousef RG, Elkady H, Gobaara IMM, Alsfouk BA, Husein DZ, Ibrahim IM, Metwaly AM, Eissa IH. Design, Synthesis, Docking, DFT, MD Simulation Studies of a New Nicotinamide-Based Derivative: In Vitro Anticancer and VEGFR-2 Inhibitory Effects. Molecules 2022;27:4606. [DOI: 10.3390/molecules27144606] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 25 |
Elkaeed EB, Yousef RG, Elkady H, Gobaara IMM, Alsfouk AA, Husein DZ, Ibrahim IM, Metwaly AM, Eissa IH. The Assessment of Anticancer and VEGFR-2 Inhibitory Activities of a New 1H-Indole Derivative: In Silico and In Vitro Approaches. Processes 2022;10:1391. [DOI: 10.3390/pr10071391] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 26 |
Elrebehy MA, Al-Saeed S, Gamal S, El-Sayed A, Ahmed AA, Waheed O, Ismail A, El-Mahdy HA, Sallam AM, Doghish AS. miRNAs as cornerstones in colorectal cancer pathogenesis and resistance to therapy: A spotlight on signaling pathways interplay - A review. Int J Biol Macromol 2022:S0141-8130(22)01348-4. [PMID: 35768045 DOI: 10.1016/j.ijbiomac.2022.06.134] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 27 |
Yousef RG, Eldehna WM, Elwan A, Abdelaziz AS, Mehany ABM, Gobaara IMM, Alsfouk BA, Elkaeed EB, Metwaly AM, Eissa IH. Design, Synthesis, In Silico and In Vitro Studies of New Immunomodulatory Anticancer Nicotinamide Derivatives Targeting VEGFR-2. Molecules 2022;27:4079. [DOI: 10.3390/molecules27134079] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 28 |
Elkaeed EB, Youssef FS, Eissa IH, Elkady H, Alsfouk AA, Ashour ML, El Hassab MA, Abou-seri SM, Metwaly AM. Multi-Step In Silico Discovery of Natural Drugs against COVID-19 Targeting Main Protease. IJMS 2022;23:6912. [DOI: 10.3390/ijms23136912] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 16.0] [Reference Citation Analysis]
|
| 29 |
El-Mahdy HA, Sallam AM, Ismail A, Elkhawaga SY, Elrebehy MA, Doghish AS. miRNAs inspirations in hepatocellular carcinoma: Detrimental and favorable aspects of key performers. Pathol Res Pract 2022;233:153886. [PMID: 35405621 DOI: 10.1016/j.prp.2022.153886] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
